How can this happen so quickly with the new COVID-19 vaccines?
Many are wondering that right now. Of course the question is justified, but the possible answers are not as blatantly incomprehensible and conspiratorial as some fear or whisper around.
First of all, it is just that the development of these vaccines has been made the top priority, other projects may have been postponed. Due to the competitive pressure, an enormous amount of energy and time was simply put into it, practically everything condensed.
Funds were certainly prioritized for this. When suddenly a completely different financial strength is there, you can of course push the development forward faster than usual. More staff, faster development of professional systems, purchase of expertise etc.
In addition, there was already a lot of prior knowledge about mRNA vaccines, for example, completely new technologies for vaccine production and preservation are there, everyone works together so that synergies result that lead to a faster end result and faster production.
Of course, the companies are ready to take an even higher risk at the moment. Such developments cost millions to billions and without a pandemic one would certainly not be putting everything on 1 card. That can of course also go wrong, then we are all unlucky.
COVID-19 biotech response compared to previous health threats 2003-2019 | Statista
Biotech companies started clinical trials on potential treatments for COVID-19 just three months after the genetic…
Response time for SARS (2003): 20 months
Response time for COVID-19 (2019): 3.1 months
In addition, the various phases of vaccine testing (phase I-III and before that, of course, the preclinical, basic research experiments) are not done one after the other but sometimes at the same time. That means nothing is left out, just checked & evaluated at the same time.
When the data is there, it is not first collected for a long time, published in any specialist magazine, taken apart and…